Followers | 117 |
Posts | 10384 |
Boards Moderated | 1 |
Alias Born | 11/27/2015 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, August 19, 2018 9:03:14 PM
The great part about this investment is that there is only about 178 investors in this. I almost feel like most of them aren't even following this. We are getting like 15 trades all day one day, and only 9 the next. On Friday we had 28 trades. When new investors start pouring in this will go way up. When I do DD on this there is such little information, all of which can be found on Oncbiomune's website. Even their facebook page has been quiet for a while.
I really don't see anyone losing money who get in now. Even if the trials fail from this point on, there has been enough proof that this works for some. That alone is enough to make this worth millions. The only down side to this is competition. I always feel when in to these pharmaceutical stocks that there is a race against the competition. After listening and reviewing the AACR documents and videos, there are quite a few companies out there on the scene. Of course I believe Oncbiomune is currently in the lead.
If you want check out this pdf, be warned it is a huge document if you download:
https://www.aacr.org/Documents/canprog18_All.pdf
This was the page I found our poster on:
http://aacr18.posterview.com/nosl/?sessionid=195
OBMP's poster is CT061
The material out there is overwhelming. On the other hand, it just goes to show how important and necessary it is to find cures for cancer. Huge value is successful which I honestly believe we are going to be.
As an investor however, I still have to day trade, sell short term, and hold long term.
GO OBMP$
$OBMP
$OBMP
$OBMP
Recent THER News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:29:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 08:35:09 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/15/2024 10:28:54 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 08:00:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 01:10:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:28:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:17:03 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 12/29/2023 04:26:15 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:51:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:08:50 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 08:46:06 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM